MedDataX Logo

Dietary Intervention in Follicular Lymphoma

NCT00455416 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2008-05-21

No results posted yet for this study

Summary

A dietary intervention study in patients with Follicular Lymphoma (FL) Stage III/IV to assess the ability of several dietary factors to induce apoptosis, inhibit cell proliferation and modulate tumor cell infiltrate in vivo.

Conditions

  • Follicular Lymphoma

Interventions

DRUG

Omega 3 fatty acids (EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid))

1000mgx5 daily

DRUG

Selenium (L-Selenomethionine),

100mcgx2 daily

DRUG

Garlic extract (Allicin)

6 garlic pearls daily

DRUG

Pomegranate juice (ellagic acid)

Pomegranate juice 100%, 660ml /495 ml every second day.

DRUG

Grape juice (resveratrol, quercetin)

Merlot grape juice 100%, 660ml /495 ml every second day

DRUG

Green Tea (Epigallocathechin gallate)

Green Tea. 2 cups daily

Sponsors & Collaborators

  • University of Oslo

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Harald Jr. Holte, MD, PhD · RRHF Rikshospitalet Radiumhospitalet HF

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2009-04-30
Completion
2009-12-31

Countries

  • Norway

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00455416 on ClinicalTrials.gov